Skip to content

Dentsply Sirona

US · XRAY #2904 by market cap Listed 1970
8.54 +0.02 +0.23%
Live - 5344 symbols - heartbeat 348s ago · 2026-10-08 08:21
Pre-market 8.48 -0.70%
After-hours 8.41 -1.52%
Market cap
1.70B
P/B
1.26
EPS
-3.00
Reader sentiment Are you bullish or bearish on XRAY?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Mixed / stable
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Institutional ownership

Held by institutions
115.87% +0.06pp
Institutions
431 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund90.32%
Hedge Fund18.40%
Public Company3.56%
Private Company1.47%
Government Pension Fund1.32%
Individual/Insider0.49%
Family Office/Trust0.35%
Insurance Company0.24%
Sovereign Wealth Fund0.10%

Top holders as of 2026-06-30

BlackRock 13.40% · 26.71M sh
Fuller & Thaler Asset Management, Inc. 6.37% · 12.70M sh
Vanguard Portfolio Management, LLC 5.91% · 11.78M sh
Vanguard Capital Management, LLC 5.21% · 10.38M sh
AQR Capital Management 5.20% · 10.37M sh
State Street Global Advisors 4.66% · 9.29M sh
Lazard Asset Management LLC 4.15% · 8.27M sh
Ariel Investments, LLC 4.03% · 8.03M sh
Southpoint Capital Advisors LP 3.51% · 7.00M sh
Cooke & Bieler, L.P. 3.48% · 6.93M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 39 buys · 7 sells

NameRoleStake
Simon Campion Chief Executive Officer 0.11%
Gregory Lucier Independent Director 0.07%
Robert Johnson Senior VP & Chief Supply Chain Officer 0.04%
Andreas Frank Executive Vice President & Chief Business Officer 0.04%
Leslie Varon Independent Director 0.03%
Clyde Hosein Independent Director 0.02%
Janet Vergis Independent Director 0.02%
William Deese Independent Director 0.02%
Kevin Czerney Vice President & Chief Accounting Office 0.02%
Brian Gladden Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-29 Jonathan Mazelsky Independent Director Other Derivative Acquisition +3,323 --
2026-08-09 John Fortson Chief Financial Officer Other Acquisition +24,014 --
2026-08-09 John Fortson Chief Financial Officer Other Derivative Acquisition +104,200 $12.83
2026-08-06 Andrea Frohning Chief Human Resources Officer Sale to Issuer -802 $12.12
2026-06-29 Jonathan Mazelsky Independent Director Other Derivative Acquisition +2,841 --
2026-06-14 Clyde Hosein Independent Director Open Market Acquisition +6,500 $9.99
2026-06-14 Brian Gladden Director Open Market Acquisition +9,985 $10.02
2026-06-11 Brian McKeon Director Open Market Acquisition +10,000 $10.12
2026-06-11 Jonathan Mazelsky Independent Director Open Market Acquisition +10,000 $10.14
2026-06-10 Betsy Holden Independent Director Open Market Acquisition +10,086 $9.88
2026-06-10 Michael Barber Director Open Market Acquisition +15,175 $9.89
2026-06-07 Lindi Barton-Brobst Interim General Counsel & Assistant Secretary Initial Statement of Beneficial 0 --
2026-06-02 Clyde Hosein Independent Director Other Acquisition +22,822 --
2026-06-02 Betsy Holden Independent Director Other Acquisition +22,822 --
2026-06-02 Leslie Varon Independent Director Other Acquisition +22,822 --
2026-06-02 James Forbes Director Other Acquisition +28,887 --
2026-06-02 Brian Gladden Director Other Acquisition +22,822 --
2026-06-02 Gregory Lucier Independent Director Other Acquisition +76,764 --
2026-06-02 Gregory Lucier Independent Director Other Disposition -38,382 --
2026-06-02 Gregory Lucier Independent Director Other Derivative Acquisition +21,800 $9.64

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:21:06 · For reference only, not investment advice and not tailored to your situation.